Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenePharma, also known as Suzhou Genmedicine Medical Technology, is a leading Chinese biotechnology company specializing in the development and manufacturing of RNA-based therapeutics and research reagents. The company provides a comprehensive suite of services including siRNA, miRNA, and mRNA synthesis, as well as advanced delivery technologies like lipid nanoparticles (LNP). GenePharma operates as both a product developer with an internal pipeline focused on oncology and infectious diseases, and as a high-tech service provider (CRO/CDMO) for the global life sciences community. With state-of-the-art facilities in Suzhou and Shanghai, the company is a key player in the advancement of RNA interference (RNAi) and nucleic acid drug development in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Genmedicine Medical Technology.